NAMS MENOPAUSE CERTIFICATION EXAM QUESTIONS COMPLETE WITH 100% CORRECT ANSWERS AND DETAILED RATIONALES

NAMS MENOPAUSE CERTIFICATION EXAM QUESTIONS COMPLETE WITH 100% CORRECT ANSWERS AND DETAILED RATIONALES 1. What is considered the potentially superior marker of menopause? A) FSH B) Estradiol C) AMH D) Inhibin B Correct Answer: C) AMH Rationale: AMH is considered the potentially superior marker of menopause compared to FSH, which has many pitfalls and is variable. AMH is produced by granulosa cells and reflects ovarian follicle reserve. ________________________________________ 2. Where are estrogen receptors located? A) Only in the uterus and breasts B) Vagina, vulva, urethra, and trigone of the bladder C) Ovaries and fallopian tubes only D) Bones and brain only Correct Answer: B) Vagina, vulva, urethra, and trigone of the bladder Rationale: Estrogen receptors are located in the vagina, vulva, urethra, and trigone of the bladder. This distribution explains the genitourinary effects of estrogen deprivation during menopause. ________________________________________ 3. What are the effects of estrogen on tissue? A) Decrease blood flow and collagen production B) Maintain blood flow, collagen, and hyaluronic acid within epithelial surfaces C) Only affect bone density D) Reduce microbiome diversity Correct Answer: B) Maintain blood flow, collagen, and hyaluronic acid within epithelial surfaces Rationale: Estrogen maintains blood flow, collagen, and hyaluronic acid within epithelial surfaces, supports the microbiome, and protects tissue from pathogens. ________________________________________ 4. Which vaginal changes occur with menopause? A) Thickening and increased elasticity B) Thinning, loss of elasticity, and loss of rugae C) Increased rugae and elasticity D) No significant changes Correct Answer: B) Thinning, loss of elasticity, and loss of rugae Rationale: Menopause causes vaginal thinning, loss of elasticity, and loss or absence of rugae due to estrogen deficiency. ________________________________________ 5. What happens to the vagina and urethra during menopause? A) Both widen and lengthen B) Vagina narrows, urethra moves closer to the introitus C) Vagina widens, urethra moves away from introitus D) No anatomical changes occur Correct Answer: B) Vagina narrows, urethra moves closer to the introitus Rationale: During menopause, the vagina narrows and the urethra moves closer to the introitus due to estrogen deficiency affecting tissue support. ________________________________________ 6. Which type of urinary incontinence does vaginal estrogen help with? A) Urge urinary incontinence B) Stress urinary incontinence C) Overflow incontinence D) Functional incontinence Correct Answer: B) Stress urinary incontinence Rationale: Vaginal estrogen specifically helps with stress urinary incontinence by improving urethral and vaginal tissue integrity. ________________________________________ 7. What treatments are used for female pattern hair loss (FPHL)? A) Only minoxidil B) Minoxidil, spironolactone, finasteride, and estrogen therapy C) Only spironolactone D) Only finasteride Correct Answer: B) Minoxidil, spironolactone, finasteride, and estrogen therapy Rationale: Treatment options for FPHL include minoxidil, spironolactone, finasteride, and estrogen therapy. ________________________________________ 8. In late reproductive years stage -3b, what happens with menstrual cycles, FSH, AMH, AFC, and inhibin? A) Menstrual cycles normal, FSH normal, AMH low, AFC low, inhibin low B) Menstrual cycles abnormal, FSH high, AMH normal, AFC normal, inhibin normal C) Menstrual cycles normal, FSH high, AMH low, AFC normal, inhibin low D) Menstrual cycles abnormal, FSH low, AMH low, AFC low, inhibin low Correct Answer: A) Menstrual cycles normal, FSH normal, AMH low, AFC low, inhibin low Rationale: In stage -3b, menstrual cycles remain normal and FSH is normal, but AMH, AFC (antral follicle count), and inhibin are all low. ________________________________________ 9. In late reproductive years stage -3a, what happens with menstrual cycles, FSH, AMH, AFC, and inhibin? A) All parameters remain normal B) Subtle menstrual changes, variable FSH, AMH low, AFC low, inhibin low C) Menstrual cycles normal, FSH normal, AMH normal, AFC low, inhibin low D) Significant menstrual changes, FSH high, AMH low, AFC low, inhibin normal